EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

CareCloud, Inc. (CCLD) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of CareCloud, Inc. $4.67, price $2.02, upside +131.0%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US14167R1005

CI CareCloud, Inc. logo Some data Oct 1, 2026

CareCloud, Inc.

CCLD · US

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value $4.67 · Strongly undervalued (+131.0%)
✓Quality 62/100
!Weak Growth (revenue 5y +2.8 %/yr)
!Thin margins · 7.9% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (10/11)
!Moderate moat 51/100
!Evidence only medium, so the estimate is less certain
Watch CareCloud, Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$8.98 $0.7475 Fair Value $4.67 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 1, 2026.

How to read this chart

60‑month range $0.7475 – $8.98 · fair‑value band $3.26 – $6.06 · the $2.02 price screens below the $4.67 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 1, 2026.

Follow CareCloud in your weekly email

Every Wednesday you see whether CareCloud is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

CareCloud, Inc., a healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates through Healthcare IT and Medical Practice Management segments.

Show more

CareCloud, Inc., a healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates through Healthcare IT and Medical Practice Management segments. The company's proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; MAP App; and medical practice management services. It also offers revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, Stratus AI Desk Agent, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; professional services; managed services; workforce augmentation; on-demand staffing; and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, therapists, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Stock analysis

CareCloud, Inc. (CCLD) currently trades at $2.02, while our model-based Fair Value estimate is $4.67, implying the stock looks roughly 56.7% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $7.35 per share, and 21 of the 26 models we run sit above the $2.02 price.

Bear case: the Asset-Based group reads lowest at $0.9400, and 5 of the 26 models stay below the price. Evidence for this calculation is medium.

Scenario range: $3.26 (bear) to $6.06 (bull), the price of $2.02 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

CareCloud, Inc. reported revenue of $120M in FY2025 versus $140M in FY2021, a compound −3.6%/yr. Reported net income was $10.8M in FY2025, compounding +39.7%/yr from FY2021.

Key figures

Market cap $92.6M · P/E ratio 15.5 · P/S ratio 1.39 · EPS (TTM) $0.1300 · Dividend yield 6.8% · Net margin 9.0% · Return on equity 17.4% · Return on assets (EBIT) −5.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 47% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 131%, CCLD screens cheaper than that median.

Fair Value models

Bear $3.26 Fair Value $4.67 Bull $6.06
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.0983 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $4.86 $8.19 $13.26 76
Growth DCF $4.73 $7.49 $11.36 75
EPV $1.80 $2.01 $2.18 74
All 26 models by family
DCF Models
FCF DCF $4.86 $8.19 $13.26 76
Owner Earnings $4.68 $7.88 $12.76 72
5Y Revenue Exit $3.42 $5.49 $8.27 69
5Y EBITDA Exit $5.86 $10.73 $17.02 71
5Y P/E Exit $4.28 $7.35 $10.92 67
10Y Revenue Exit $3.87 $5.92 $9.01 64
10Y EBITDA Exit $5.35 $9.28 $15.52 64
10Y P/E Exit $4.44 $7.11 $10.98 61
Earnings-Based
Graham-Dodd $1.73 $9.21 $12.75 61
Lynch FV $2.54 $3.63 $4.72 59
PEG = 1.0 $2.54 $3.63 $4.72 55
EPV $1.80 $2.01 $2.18 74
Dividend Discount
Gordon GGM $1.03 $1.73 $2.24 66
DDM Multi-Stage $1.03 $1.64 $1.86 65
Multiples
P/E Multiple $4.19 $5.59 $6.99 63
P/S Multiple $3.24 $4.32 $5.40 58
P/B Multiple $3.24 $4.32 $5.40 55
EV/EBIT $3.51 $4.66 $5.81 66
EV/EBITDA $7.10 $9.44 $11.79 67
EV/Revenue $2.53 $3.58 $4.64 54
Asset-Based
NCAV (Graham) $0.7000 $0.9400 $1.40 54
Growth DCF
Growth DCF $4.73 $7.49 $11.36 75
Rev-Margin DCF $3.42 $5.48 $8.27 69
Economic Profit
Residual Income $1.36 $1.68 $2.28 73
ROIC Compounder $1.94 $2.42 $3.01 70
Growth Earnings
Growth-Adj P/E $3.84 $5.49 $7.13 65

Open the full fair value analysis →

Notify me when CCLD reaches fair value

Put CCLD on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 62/100

Of which business quality 65 · Market factors (momentum, volatility) 9

Profitability 77
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 79
Earnings quality: real cash, not paper profit
Fin. Strength 78
Balance sheet, leverage, solvency risk
Investment 91
Disciplined investing over empire-building
Low Volatility 11
Calm price path (market factor)
Momentum 13
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+8.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
Start year 2020 (pandemic). Over 10 years: +18.0% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.4%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−25.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−32.0%
Dividend (yield on the price)6.8%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−8% → 10%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+33.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+6.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +29.9% a year for the price and +4.5% for the forecasts.
Forecast 2026 (sales)+8.7%
Forecast 2027 (sales)+7.6%
Projected 2028 (sales)+6.9%
Projected 2029 (sales)+6.2%
Projected 2030 (sales)+5.5%

Watch CCLD, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare CareCloud, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 116 stocks

Beats the industry median on 10/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 62 · Above median
Fair Value upside +128.8% · Top 25%
Profitability
Return on equity (TTM) 17.4% · Top 25%
Return on assets 8.1% · Top 25%
Net margin (TTM) 7.9% · Above median
Operating margin (TTM) 3.4% · Below median
Growth and dividend
Revenue growth 13.2% · Above median
Dividend yield (TTM) 6.8% · Top 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/E (TTM) 15.5× · Cheapest 25%
PEG 0.31× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)66 · sector 48
PAST (return on equity)69 · sector 12
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)100 · sector 44

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $278.57 $306.43 +10%
Pro Medicus Limited PME A$161.00 A$84.62 −47%
BrightSpring Health Services, Inc BTSG $56.54 $25.86 −54%
Hinge Health, Inc HNGE $95.57 $51.25 −46%
HealthEquity, Inc HQY $88.44 $97.28 +10%
Waystar Holding WAY $24.70 $27.17 +10%
Doximity, Inc DOCS $26.35 $31.41 +19%
XtalPi Holdings 2228 HK$7.75 HK$1.50 −81%
Inventurus Knowledge Solutions Limited IKS ₹1,779 ₹1,883 +6%
Privia Health Group PRVA $19.62 $5.02 −74%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

CareCloud, Inc. · Fair Value
$4.67 +57%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "CareCloud, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/CCLD

Frequently asked questions

Is CareCloud, Inc. (CCLD) overvalued or undervalued?
As of Oct 1, 2026, our model estimates a fair value of $4.67 versus a price of $2.02, about +131% upside (undervalued).
What is the fair value of CCLD?
Our model-based fair value for CareCloud, Inc. is $4.67 (as of Oct 1, 2026), built from audited fundamentals. The current price: $2.02.
What is the quality score of CCLD?
CareCloud, Inc. has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CareCloud, Inc. (CCLD)?
Our model-based price target is the fair value of $4.67 (as of Oct 1, 2026) from 26 valuation models. Cautious scenario $3.26, optimistic scenario $6.06. It is a calculation from audited fundamentals, not an analyst target.
What is the CareCloud, Inc. stock forecast for 2026?
Our models put fair value at $4.67, about +131% upside versus a price of $2.02 (undervalued). Cautious scenario $3.26, optimistic scenario $6.06. The calculation is refreshed regularly with new filings.
What is the revenue of CareCloud, Inc. (CCLD)?
CareCloud, Inc. reported trailing-twelve-month revenue of about $124M (latest available figure, as of Oct 1, 2026).
Does CareCloud, Inc. pay a dividend?
CareCloud, Inc. currently shows a dividend yield of about 6.80% relative to its recent price (as of Oct 1, 2026).
What growth is priced into CareCloud, Inc. (CCLD)?
For today's price to be fair in a discounted-cash-flow model, CareCloud, Inc. would have to grow free cash flow by +33.0 % per year for five years (discount rate 14.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.8 % per year. As of Oct 1, 2026.
What discount rate (WACC) does the fair value of CCLD use?
Our models discount CareCloud, Inc. at 14.3 %: a base by market capitalisation (micro), damped by beta 1.51, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CareCloud, Inc. that is +33.0 % per year a year over ten years, using the same discount rate (14.3 %) and the same formula as our fair value.
How much growth has CareCloud, Inc. (CCLD) delivered so far?
Over the past 5 years revenue at CareCloud, Inc. grew +2.8 % a year. The price currently implies +33.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CareCloud, Inc. (CCLD) growing?
The median revenue growth in the sector is +5.1 % a year. That is the yardstick for the growth priced into CareCloud, Inc. (+33.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CareCloud, Inc. (CCLD)?
The free-cash-flow yield on the price is 2.68 %: that much free cash flow CareCloud, Inc. produces per unit of market value. When it exceeds the discount rate of our models (14.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CareCloud, Inc. (CCLD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CareCloud, Inc. it is $4.67 per share (as of Oct 1, 2026), against a price of $2.02. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is CareCloud, Inc. stock overvalued or undervalued in 2026?
As of Oct 1, 2026, CCLD trades below its calculated fair value: price $2.02, fair value $4.67, a gap of about +131% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CCLD?
No. The price is what the market pays today ($2.02); the fair value is what the company's own numbers justify ($4.67). For CareCloud, Inc. the two are $2.65 per share apart. That gap is exactly why we show both numbers side by side.
How much is CareCloud, Inc. worth?
The market values CareCloud, Inc. at about $92.6M (market capitalisation, as of Oct 1, 2026). Per share that is $2.02; our models calculate a fair value of $4.67 per share.
What do the bullish and bearish scenarios say about CCLD?
Our models span a range for CareCloud, Inc.: cautious scenario $3.26, base $4.67, optimistic $6.06 per share (as of Oct 1, 2026, price $2.02). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CCLD?
CareCloud, Inc. trades at a price-to-earnings ratio of 15.5 (as of Oct 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $4.67 is built from several models across several years. Other multiples: PEG 0.3.
What is the PEG ratio of CCLD?
The PEG ratio of CareCloud, Inc. is 0.31 (P/E divided by earnings growth, as of Oct 1, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of CareCloud, Inc. (CCLD)?
Balance-sheet figures for CareCloud, Inc. (as of Oct 1, 2026): return on equity 17.4%, debt of 0.01 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is CCLD from its 52-week high?
CareCloud, Inc. trades at $2.02, about 47% below its 52-week high of $3.81 and at the low of $2.02 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $4.67 is for.
Which stocks are comparable to CareCloud, Inc.?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CareCloud, Inc. stock attractive at the current price?
The data as of Oct 1, 2026: price $2.02, calculated fair value $4.67 (+131%), Quality Score 62/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CCLD calculated?
We run CareCloud, Inc. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.67, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. CareCloud, Inc. currently trades 57 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CareCloud, Inc. (CCLD)?
The closing price on Oct 2, 2026 was $2.02. Our model-based fair value is $4.67, about +131% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CareCloud, Inc. right now?
The price is below even our cautious bear case ($3.26). The market is more pessimistic than our downside scenario. Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($3.26 to $6.06) leaves room in how you read the outcome.

Key figures of CareCloud, Inc.

How large is the market capitalisation of CareCloud, Inc. (CCLD)?
The market capitalisation of CareCloud, Inc. is $92.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CareCloud, Inc. (CCLD)?
The price-to-sales ratio of CareCloud, Inc. is 1.39 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CareCloud, Inc. (CCLD)?
Earnings per share at CareCloud, Inc. are $0.1300 (price ÷ EPS = P/E 15.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of CareCloud, Inc. (CCLD)?
The dividend yield of CareCloud, Inc. is 6.8% (payout 106%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CareCloud, Inc. (CCLD)?
The net margin of CareCloud, Inc. is 9.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CareCloud, Inc. (CCLD)?
The return on equity (ROE) of CareCloud, Inc. is 17.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CareCloud, Inc. (CCLD)?
On an EBIT basis the return on assets of CareCloud, Inc. is −5.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CareCloud, Inc. (CCLD)?
The operating margin of CareCloud, Inc. is 3.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CareCloud, Inc. (CCLD)?
Revenue at CareCloud, Inc. is growing +13.2% versus a year earlier (3y avg −4.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CareCloud, Inc. (CCLD)?
Earnings per share at CareCloud, Inc. are growing +57.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does CareCloud, Inc. (CCLD) carry?
The net debt of CareCloud, Inc. is $1.2M (fiscal year 2025, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch CareCloud, Inc. in the live analysis

One click puts CareCloud, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.